Back

Evaluation of the hypothetical risk of sudden cardiac death in obstructive HCM patients treated with mavacamten using the HCM Risk-SCD score

29 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy, ventricular arrhythmias, and sudden cardiac death Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Mariana Silveira Ramos

Hospital Santa Cruz, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Long-term outcomes of hypertrophic cardiomyopathy patients undergoing septal reduction therapies: Results from the NHLBI HCMR registry
Doctor M. Desai (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
Stability-driven phenotype clustering of children with hypertrophic cardiomyopathy identifies phenogroups with distinct outcomes
Miss C. Taylor (London, GB)
Abstract Slides Video
Presentation thumbnail
Clinical profile of patients with hypertrophic cardiomyopathy and recurrent ventricular arrhythmias
Doctor O. Galvin (Galway, IE)
Abstract Slides Video
Presentation thumbnail
Head-to-head comparison of ESC 2023 and 2024 ACC/AHA primary-prevention ICD selection strategies in hypertrophic cardiomyopathy: insights from a real-world ICD-implanted cohort
Doctor A. Diaz Exposito (Malaga, ES)
Abstract Slides Video
Presentation thumbnail
Performance of HCM Risk-SCD in patients with ICD: insights from a brazilian population
Doctor I. Raduan Brigo (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy, ventricular arrhythmias, and sudden cardiac death

The Event

Event poster

ESC Congress 2026

29 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of Mavacamten on reducing sudden cardiac death risk in patients with Obstructive Hypertrophic Cardiomyopathy: an evaluation using the HCM-SCD Risk Score
31 March 2025
thumbnail
Congress Presentation
Baseline global longitudinal strain and mechanical dispersion predict ejection fraction decline during mavacamten therapy in obstructive hypertrophic cardiomyopathy
29 August 2026
thumbnail
Congress Presentation
HCM in the modern era: low mortality and predominantly predictable sudden cardiac death under systematic risk stratification
30 August 2026
thumbnail
Congress Presentation
Refining arrhythmic risk stratification in hypertrophic cardiomyopathy through left atrial volume and strain
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources